Riskpilot← Back to searchSign inGet full accessDR. ROARSEN AS
ASActiveOrg 911663791Glassverkveien 30B, 1363 HøvikGeneral medical practice activities · NACE 8621Est. 20132 employees
Revenue 2024
NOK 26,8M
+22% vs 2023
EBITDA margin
57.1%
+9% vs 2023
Equity ratio
77.8%
Financial strength
Net profit 2024
NOK 11,8M
+8% vs 2023
| Revenue | NOK 26,8M | +22% |
| EBITDA | NOK 15,3M | +9% |
| Net profit | NOK 11,8M | +8% |
| Total assets | NOK 20,5M | +23% |
| Equity | NOK 16M | +32% |
| Employees | 2 | — |
Legal name
DR. ROARSEN AS
Org number
911663791
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
6. mars 2013
Share capital
NOK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Generell helsevirksomhet og forretningsutvikling innen helsesektoren. Investere og eie aksjer i andre selskaper samt hva som herav står i naturlig forbindelse.
Address
Glassverkveien 30B, 1363 Høvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 940 | 3 688 | 4 049 | 4 997 | 7 601 | 6 098 | 8 897 | 11 566 | 14 742 | 17 494 | 22 015 | 26 832 |
| Staff expenses | −668 | −734 | −904 | −788 | −975 | −1 022 | −1 119 | −1 033 | −1 235 | −1 271 | −2 286 | −3 684 |
| EBITDA | 1 793 | 2 276 | 2 530 | 3 544 | 5 805 | 3 924 | 5 406 | 6 637 | 9 449 | 11 248 | 14 082 | 15 326 |
| Depreciation & amort. | −10 | −11 | −11 | −0 | −22 | −0 | −0 | −5 | −25 | −61 | −61 | −61 |
| EBIT | 1 783 | 2 265 | 2 520 | 3 544 | 5 783 | 3 924 | 5 406 | 6 632 | 9 425 | 11 188 | 14 021 | 15 265 |
| Net financials | 0 | 39 | 23 | 338 | 1 516 | −2 021 | 19 | 9 | 7 | 11 | 78 | 271 |
| Profit before tax | 1 784 | 2 304 | 2 543 | 3 882 | 7 299 | 1 903 | 5 425 | 6 641 | 9 432 | 11 199 | 14 100 | 15 536 |
| Tax | 509 | 628 | 691 | 884 | 1 524 | 903 | 1 191 | 1 517 | 2 123 | 2 521 | 3 108 | 3 693 |
| Net profit | 1 275 | 1 676 | 1 852 | 2 998 | 5 775 | 1 000 | 4 234 | 5 124 | 7 310 | 8 678 | 10 992 | 11 843 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 214 | 3 795 | 4 464 | 4 767 | 8 019 | 8 524 | 9 271 | 11 093 | 10 208 | 13 600 | 16 657 | 20 503 |
| Equity | 1 325 | 3 001 | 677 | 675 | 6 450 | 7 450 | 3 683 | 3 807 | 1 716 | 9 751 | 12 107 | 15 950 |
| Long-term debt | 8 | 10 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 881 | 784 | 3 783 | 4 092 | 1 569 | 1 075 | 5 588 | 7 286 | 8 492 | 3 849 | 4 549 | 4 553 |
| Total debt | 890 | 794 | 3 788 | 4 092 | 1 569 | 1 075 | 5 588 | 7 287 | 8 492 | 3 849 | 4 549 | 4 553 |
EBITDA margin
57.1%
This company
15.8%
Market median
+261% vs market
20132024
Equity ratio
77.8%
This company
38.2%
Market median
+104% vs market
20132024
Return on equity
74.2%
This company
18.4%
Market median
+303% vs market
20132024
Net profit margin
44.1%
This company
8.1%
Market median
+444% vs market
20132024
Asset turnover
1.31×
This company
1.12×
Market median
+17% vs market
20132024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DR. ROARSEN AS 
AGRO ØRE-NESE-HALSKLINIKK ASBoard members of DR. ROARSEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Robby Roarsen | Chairman | 0 companies |